CorTechs Labs Presents Findings on the Creation of Machine Learning Models to Aid Early, Accurate Diagnosis of MS at ACTRIMS 2020

Companies in the Global Vaccine Delivery Devices Market Expedite Product Innovations to Stay at Forefront in the Market in the COVID-19 Pandemic

Fact.MR has recently compiled a report, which reveals that the vaccine delivery devices market globally is projected to reflect an impressive CAGR over the forecast period, 2017 – 2022.

Sirtex Medical and BlackSwan Vascular Report 1st Patient Enrolled in Pivotal LAVA Study

The LAVA Study, which stands for Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S.

Cohen Children’s Medical Center: Covid-19 Teen Returns to Thank the Doctor Who Saved Her Life

It was nothing but bright sunshine at Cohen Children’s Medical Center when Karla Duarte, the first teenager in American to be treated for COVID-19 with extracorporeal membrane oxygenation (ECMO) stopped by to thank the medical team on the one-year anniversary of her discharge.

CorTechs Labs reports in the study “Performance Evaluation for MS Identification Models”, CorTechs Labs used a recent version of their flagship product, NeuroQuant 3.0, to compute volumetric brain measurements to train an AI algorithm to create machine learning models for different age ranges to classify multiple sclerosis (MS) subjects. They evaluated the performance of these models for identifying MS subjects and studied the differences of feature importance selected by the models based on whole and specific age range data. The company will be presenting its findings at the conference around the understanding that studying volumetric changes in the brain can lead to a much deeper understanding of the effects and symptoms of MS as a disease, and that these models may be used as MS classifiers to assist clinicians in decision making.

“We are dedicated to improving patient outcomes and up-leveling the standard of patient care through best in class clinical applications and patient-centric analysis and reporting,” said Chris Airriess, Ph.D., chief executive officer of CorTechs Labs. “Having two very close friends with the disease, I have seen firsthand the impact MS can have on the lives of patients and their families. We work hard every day to provide software solutions to enable early, accurate diagnosis of MS to ultimately help patients get the treatment they need as soon as possible – and to monitor treatment response to ensure the best possible outcomes. The research being presented at ACTRIMS provides hope for furthering these advancements in the diagnosis and classification of MS.”

CorTechs Labs will have the following two poster presentations at ACTRIMS 2020:

  • Friday, February 28, 11:00 a.m.-12:00 p.m. ET: Performance Evaluation for Multiple Sclerosis Identification Models Based on MR Imaging and Machine Learning (Board No. P183). Presented by Weidong Luo, Ph.D., principal scientist.
  • Session: Poster Session 2 Lunch
  • Friday, February 28, 12:00-1:00 p.m. ET: Updated Recommendations for a Standardized MRI Protocol for Multiple Sclerosis (Board No. LB310). Presented by The Consortium of MS Centers in partnership with select experts for their input and co-authorship, including Marilyn Maes, M.S., RT, clinical specialist and Amy Verrinder, vice president of sales.
  • Session: Poster Session 2 Lunch

CorTechs Labs’ cutting-edge brain imaging analysis provides neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effective means to quantify brain structures to help assess a variety of neurodegenerative conditions.



Related Articles